Nick,
I'm sorry to hear the bad news, but rest assured that with your intermediate risk cancer you still have quite a few options to explore. The first order of business, however, is to get a second opinion on your biopsy from
Bostwick,
Epstein or
Oppenheimer. They only read prostate cancer slides and it is a very specialized skill.
Your options include SBRT, LDR brachy (seeds) and HDR brachy (temporary). At the best facilities, the 5-year freedom from recurrence for intermediate risk are as follows:
LDR Brachy (Dr. Taira) - 97% (12 year - may include ADT)
HDR Brachy monotherapy (GammaWest) - 94%
SBRT (8 institutions) - 93%
IMRT (Memorial Sloan Kettering - 86 Gy) - 86% (8 yr)
IMRT (" - 81 Gy) - 78% (7 yr)
Prostatectomy (Johns Hopkins) - 77%
Proton (Loma Linda) - 65% (approx)
In terms of salvage if initial therapy fails, salvage
anything will almost always have more side effects than initial therapy. Salvage radiation after surgery will have a worse outcome than if radiation had been done initially. Salvage surgery after radiation is messy, but there are some surgeons who specialize in that. More importantly, salvage after a rare local radiation failure is best handled with more brachytherapy or SBRT rather than salvage surgery. With both SBRT and HDR brachy, the total radiation dose received is only about
40 Gy, which leaves plenty of room to do it all a second time if need be -- more likely, they would do a biopsy and just treat any focal reoccurrence.
Surgeons almost always recommend surgery -- it's what they know. Radiation oncologists almost always recommend radiation -- it's what they know. Moreover, each sub-specialist (e.g., robotic surgery, seeds) will recommend his sub-specialty. That leaves the burden on you to find out more about
the other therapies. I talked to about
6 doctors before I made my decision. Please let me know if I can answer any questions.